Pulmatrix (PULM) Interest & Investment Income (2014 - 2026)
Pulmatrix (PULM) posted Interest & Investment Income of $12000.0 for Q1 2026, down 40.0% sequentially from $20000.0 in Q4 2025, and down 77.36% YoY from $53000.0 in Q1 2025.
Pulmatrix (PULM) Interest & Investment Income (2014 - 2026) Analysis & Trends
Pulmatrix has reported Interest & Investment Income for 8 years, with the latest figure at $12000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 77.36% year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103000.0 (down 71.39% YoY) and the FY2025 annual result came in at $144000.0, down 69.16% from the prior year.
- Interest & Investment Income retreated to $12000.0 in Q1 2026 per PULM's latest filing, from $20000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $133000.0 in Q2 2024 and troughed at $12000.0 in Q1 2026.
- A 3-year average of $57875.0 and a median of $47000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income slumped 69.17% in 2025, then plunged 77.36% in 2026.
- Over 3 years, Interest & Investment Income stood at $73000.0 in 2024, then sank by 72.6% to $20000.0 in 2025, then sank by 40.0% to $12000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $12000.0, $20000.0, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 101,000.00 |
| Jun 30, 2024 | 133,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 13,000.00 |
| Mar 31, 2020 | 52,000.00 |
| Dec 31, 2019 | 74,000.00 |
| Sep 30, 2019 | 121,000.00 |
| Jun 30, 2019 | 102,000.00 |
| Mar 31, 2019 | 4,000.00 |